Optogenetics Pioneers Win 2026 Nobel Prize in Medicine for Controlling Neurons With Light

The Karolinska Institute has awarded the 2026 Nobel Prize in Medicine to Karl Deisseroth of Stanford University, Peter Hegemann of Humboldt University in Berlin, and Georg Nagel of the University of Würzburg for the development of optogenetics, a technology that allows scientists to control individual nerve cells using targeted light beams.

According to Per Svenningsson, chair of the Nobel Committee for Medicine, optogenetics provides unprecedented fidelity for mapping living neural tissue, offering insights into fundamental central nervous system functions as well as psychiatric and neurological disorders. As detailed in reporting by Wired (https://www.wired.com/story/the-science-behind-the-nobel-winning-technology-that-controls-neurons-with-light/), the breakthrough stemmed from an unexpected convergence of microbiology and neuroscience.

In the late 20th century, Hegemann began studying how the single-celled alga Chlamydomonas reacts to light via an orange surface structure called an eye spot, which contains the light-sensing molecule retinal. Measuring the electrical response with microelectrodes, Hegemann found the organism produced an electrical impulse in roughly 0.5 milliseconds—about 20 times faster than the 10-millisecond response time in human vision. In the early 1990s, he proposed that a single protein acted as both light detector and ion channel.

After Japanese researchers sequenced the Chlamydomonas genome, Hegemann's laboratory identified two candidate genes. Nagel verified their function by inserting copies into frog eggs, where the expressed proteins localized to cell membranes and opened ion channels upon light exposure. Nagel named the genes channelrhodopsin-1 and channelrhodopsin-2 (ChR2), with ChR2 moving ions in just 0.2 milliseconds. When introduced into mammalian cells, the protein successfully generated light-triggered electrical signals.

Deisseroth then sought to apply the mechanism to living neural circuits to investigate conditions such as depression and schizophrenia. In 2005, Deisseroth introduced the ChR2 DNA sequence from Nagel into cultured rat neurons, demonstrating that pulses of blue light caused the cells to fire immediate electrical impulses to adjacent neurons. Coined in 2006, optogenetics has since expanded to multiple light wavelengths, and the Nobel Assembly noted the technique is now being applied in experimental efforts to restore vision in patients with visual impairments.